Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Medifast, Inc.
Type
Public
Traded as NYSE: MED
S&P 600 Component
Industry Weight loss
Founded 1980
Headquarters Owings Mills, Maryland, United States
Key people
Daniel R. Chard, CEO
Products Medifast diet
Revenue Decrease US$ 285.3 million (2014)
Operating income
Decrease US$ 30.2 million (2014)
Net income
Decrease US$ 13.2 million (2014)
Total assets Decrease US$ 115.9 million (2014)
Total equity Decrease US$ 80.5 million (2014)
Number of employees
808 (2014)
Website www.medifast1.com

Medifast, Inc. is an American nutrition and weight loss company based in Owings Mills, Maryland. The company owns five subsidiaries: Jason Pharmaceuticals, Inc. (Jason), Take Shape for Life, Inc. (TSFL), Jason Enterprises, Inc., Jason Properties, LLC and Seven Crondall, LLC. Medifast produces, distributes, and sells weight loss and other health-related products through websites, multi-level marketing, telemarketing, franchised weight loss clinics, and medical professionals.

The company is public with a market capitalization of $405 million, as of October 2014.

Medifast was founded in 1980 by William Vitale, a medical doctor. His products were sold directly to other doctors, who in turn prescribed them to their patients.

The company is publicly traded on the New York Stock Exchange (symbol: MED).

On July 17, 1995, HealthRite (predecessor of Medifast) changed its name from Vitamin Specialties Corp.

In October 2010, Medifast was ranked number 1 on Forbes magazine's list of "America's 100 Best Small Companies". The company was ranked 18th as of the 2014 list.

In September 2012, Medifast's subsidiary, Jason Pharmaceuticals, paid a $3.7 million USD civil penalty for false advertising. The Federal Trade Commission and United States Department of Justice said that advertisements for the "Medifast 5 & 1 Plan" low-calorie diet told consumers they could "lose up to 2-5 pounds per week.", and that these weight-loss claims lacked a reasonable scientific basis, and were unsubstantiated. Under the settlement, any future claims made by the company must be backed by at least one human clinical study.

Investment goal date:
Dividends reinvested
Medifast, Inc. MED report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-05-07
--
--
Q4 2017
2018-02-21
--
--
Q3 2017
2017-11-07
--
--
Q3 2017
2017-11-07
0.5500
0.5500
Q2 2017
2017-08-08
0.6300
0.6300
Q1 2017
2017-05-04
0.5100
0.5100
Q4 2016
2017-03-09
0.3400
0.3400
Q3 2016
2016-11-03
0.5100
0.5100
Q2 2016
2016-08-03
0.6300
0.2900
Q1 2016
2016-05-04
0.4200
0.3600
Q4 2015
2016-03-10
0.3300
0.3300
Q3 2015
2015-11-05
0.4500
0.4500
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
ACADIAN ASSET MANAGEMENT LLC
466550
AJO, LP
187407
AMERICAN CENTURY COMPANIES INC
144520
Bank of New York Mellon Corp
218378
BlackRock Fund Advisors
879959
BlackRock Inc.
1431868
BlackRock Institutional Trust Company, N.A.
348069
DIMENSIONAL FUND ADVISORS LP
632211
Engaged Capital LLC
789549
Invesco Ltd.
272646
KENNEDY CAPITAL MANAGEMENT, INC.
379880
Numeric Investors LLC
421069
RENAISSANCE TECHNOLOGIES LLC
954000
STATE STREET CORP
311471
Vanguard Group, Inc
643272
Major Shareholders
Name Relationship
Total Shares
Holding stocks
ModusLink Global Solutions Inc
9.3800% (1194891)
MED /
BONDROFF BARRY B
0.1100% (14533)
FMAR / MED /
MCDANIEL JOHN P
0.1400% (18289)
FMAR / MED / WRE /
MACDONALD MICHAEL C
2.8900% (368108)
MED /
MACDONALD BRADLEY T
4.5500% (579521)
MED /
TRAVIS MARY T
0.1000% (12583)
MED /
BYRNES KEVIN G
0.0600% (7756)
BYBK / MED /
SHEETZ MARGARET MACDONALD
2.5700% (327346)
MED /
MCDEVITT MICHAEL S
2.6700% (340012)
MED /
SASSANO CARL E
0.0900% (11540)
IEC / MED / TRNS /
BROWN JEFFREY J
0.1300% (16275)
MED / OUTR / RCAP /
LAW RICHARD J
0.4900% (62081)
MED /
Chard Daniel R
0.1100% (13920)
MED / NUS /
UPHOUSE JEANNE M
0.0300% (3804)
MED /
WILLIAMS LEO
0.1200% (15000)
MED /
CONNORS BRENDAN
0.7200% (91484)
MED /
CONNOLLY CHARLES P
0.3700% (47202)
MED /
MILLS JEANNETTE M
0.1600% (20116)
MED /
LAVIN GEORGE
0.1900% (24785)
MED /
MAGUIRE CATHERINE T
0.1200% (15074)
MED /
GROVES JASON L
0.1700% (21697)
MED /
BARNUM HARVEY C JR
0.0700% (8742)
MED /
REECE JERRY D
0.0700% (8792)
MED /
KAGEN BRIAN
0.0300% (3804)
MED /
GOULD DONALD
0.0500% (6804)
MED /
LLOYD BRIAN
0.0100% (1865)
MED /
VIETRI DOMINICK
0.0300% (3804)
MED /
ROBINSON TIMOTHY G
0.2200% (28044)
MED /
SHEETZ GUY
3.2200% (410430)
MED /
Welling Glenn W.
5.5900% (712189)
JMBA / MED / ROVI /
AMELI MEHRNAZ MONA
0.0700% (9489)
MED /
HALLQUIST CONSTANCE J.
0.0500% (5754)
MED /
SCHLACKMAN SCOTT
0.0400% (5382)
MED /
% ()